Iowa veteran battles through illness on Appalachian Trail journey
WHO 13 NEWS – Iowa veteran Joedy VanVelzen surpassed 800 miles, meaning he is one-third of the way done hiking the Appalachian Trail: an expedition that extends nearly 2,200 miles between Georgia and Maine and passes through 14 states.
Over the weekend, VanVelzen was at a veteran support stay in Glasgow, Virginia, recovering from Norovirus. He called it a 'minor setback' and is already back on the trail.
Earning his trail name 'Unicorn,' this mythical creature has covered a lot of ground even through a couple of health challenges, proving his physical strength and mental toughness.
The Caitlin Clark Effect: About 3 in 10 US adults follow women's sports, new poll finds
Last week, VanVelzen posted on his Facebook page that he had to make a stop at the VA Hospital in the Salem/Roanoke area of Virginia so doctors could check out a spider bite. After that was taken care of, he was back to hiking and taking lots of photos of the nature and beautiful scenery.
VanVelzen has less than 1,400 miles to go until the end of the trail in Maine. He hopes to get there by the last week of August.
If you'd like to follow along, follow his Facebook page: On the Appalachian Trail with Joedy
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
Mary Beth Nienhaus Activity Center officially opens, providing social opportunities for adults 50+
APPLETON, Wis. (WFRV) – After all of the anticipation and excitement, the Mary Beth Nienhaus Activity Center has finally opened, with a celebration event on Friday afternoon. The activity center, formerly known as the , provides adults 50 years and older with plenty of opportunities to socialize, learn and thrive. Green Bay native Tony Shalhoub to host global food docuseries on CNN From wellness studios to high-tech classrooms and gaming areas, the facility features a plethora of ways for adults looking to keep up their activity level to do so. It also features the only indoor pickleball court for adults in Appleton. The center is still holding a fundraiser, looking to raise about $6.5 million, and it is 85% of the way there. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
New York Post
21 hours ago
- New York Post
‘There's a baby in there. But it's dead:' mom shares horrific story
'Oh my god, you're pregnant.' The nurse had whispered it like a revelation. As if she had been delivering good news. But all Ash could do was blink at her. She had to once again recount her nightmare: 'That's literally the whole reason I'm here… There's a baby in there. But it's dead.' 3 'There's a baby in there. But it's dead,' a woman named Ash shared about her health issues. kidspot 'It could have been life-threatening' Ash had just completed a routine urine test ahead of surgery, which had flagged high hCG (human chorionic gonadotropin) levels. Weeks beforehand, The Gold Coast mom terminated her pregnancy after the embryo implanted in her C-section scar, left behind from her previous pregnancy. 'It would have been like life-threatening had I continued that pregnancy ' Ash revealed to Kidspot. 3 Weeks before, Ash terminated her pregnancy after the embryo implanted in her C-section scar, left behind from a previous pregnancy. Seika – The frightening list of risks she was faced with included permanent bladder damage, severe haemorrhaging and the potential need for a hysterectomy. Scar tissue doesn't stretch like the uterus does. Had the baby been left to grow with the placenta attached to her scar, the outcome could have been devastating. It is one of the rarest forms of pregnancy, so rare that many doctors hadn't had much experience with a case like hers. It meant different specialists, numerous appointments and trying to find whatever information she could online. She turned to Google, Facebook groups and TikTok to find others who had experienced the same thing. 'I tried every possible like hashtag like 'cesarean scar', 'c-section defect.' I tried all of them,' she revealed. 'It's crazy that as women, we don't even know our own bodies and how things can work. It's just… it's crazy.' Originally, after terminating her pregnancy, doctors were keen to wait for her body to absorb and pass the pregnancy. The doctors treated her with methotrexate. Only they didn't foresee the complications. Ash was in and out of emergency rooms, consistently begging doctors to do something to help. 'That led to like a cascade of months of like emergency trips to the hospital where I was having haemorrhaging bleeds and intense pain,' she said. 'I'd get to the emergency and then they would say there's nothing that we can do. You've just got to wait for this to be absorbed by your body.' The mental toll of waiting became too much. 'I snapped one day' she admitted. 'How many more emergency trips to the hospital am I going to have to go through?' 'My bladder was fully adhered to my caesarean scar defect' Throughout this process, Ash repeatedly asked for other options. She'd asked doctors to perform a D&C (dilatation and curettage). 'They're like no you can't have a D&C due to the location of the pregnancy,' she recounted. Doctors were concerned it could lead to a rupture of her uterus. After months of complications, pain, and being medically gaslit, a private surgeon in Brisbane performed a robot-assisted laparoscopic resection of her uterus. 'They cut open the uterus. He took out the old pregnancy,' she explained. 3 'It's crazy that as women, we don't even know our own bodies and how things can work. It's just… it's crazy,' Ash said. kidspot But he found something else. 'My bladder was like fully adhered to my caesarean scar defect on the outside of my uterus,' Ash revealed. 'He said it was like folded like a concertina three times and attached.' It explained so much. 'I just thought, no wonder I could never fully empty my bladder after giving birth,' she said. For Ash, it explained symptoms she had ignored for years. 'So I remember asking him 'So is this the reason why that like I could never fully empty my bladder?'' she said. 'Since the surgery my bladder has been performing like normal. Like pre-children.' 'No one's talking about this' More and more mothers are experiencing chapters of her story, and in some cases some mothers replicate her experience. 'That's what made me want to share on TikTok. The amount of women that have come into my inbox and say 'I had this, I never even knew',' Ash revealed. 'We don't even know our own bodies, because no one's talking about this.' And through all of it, one thing kept her going. Her son. 'I kept thinking, 'I have to be okay. I have to be here for him,'' she said. ' As much as I wanted this baby, I already had a little boy who needed his mum.' The door isn't closed to more children, but the risks are now clear. 'I am allowed to try again after the three month mark,' Ash said. 'But there's a chance it could be an ectopic again.' Any new pregnancy would be high-risk and require close monitoring and early delivery by repeat caesarean. 'I don't know if I'm brave enough to risk it,' she admitted. 'I want another baby… but I also want to stay alive for the one I already have.'
Yahoo
a day ago
- Yahoo
How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?
With a market cap of $14.3 billion, Hologic, Inc. (HOLX) is a Massachusetts-based medical technology firm, primarily focused on women's health. The company develops, manufactures, and sells a comprehensive suite of solutions, including molecular diagnostics, medical imaging systems, and surgical devices Companies worth $10 billion or more are generally described as 'large-cap stocks,' and Hologic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. The company benefits from robust innovation, supported by over 7,000 patents, which fuels its proprietary technologies and product differentiation. Its diagnostics segment, particularly in molecular testing, has shown strong growth, positioning Hologic well in the expanding global healthcare market. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. However, HOLX shares have retreated 24.5% from their 52-week high of $84.67 touched on Aug. 9, 2024. Meanwhile, HOLX stock has surged 3.2% over the past three months, surpassing the SPDR S&P Health Care Equipment ETF's (XHE) 4.8% plunge over the same time frame. HOLX stock has plummeted 11.3% on a YTD basis and 10.5% over the past 52 weeks, compared to XHE's 10.6% dip in 2025 and a 6.3% fall over the past year. The stock has remained consistently below its 200-day moving average since early December last year, but has climbed above its 50-day moving average since late May. On May 27, HOLX shares surged more than 14%, leading S&P 500 gainers, after reports emerged that TPG Inc. (TPG) and Blackstone Inc. (BX) made (and were turned down on) a non-binding ~$16 billion takeover bid, valuing the company at $70–$72 per share. The stock's rally reflected investor optimism and underscored the premium valuation placed on its leadership in women's health and diagnostic capabilities. In the competitive healthcare equipment industry, top rival, Align Technology, Inc.'s (ALGN) 13.7% drop on a YTD basis and 25.7% decline over the past year trails HOLX's losses in the same time frames. Among the 19 analysts covering the HOLX stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $68.27 suggests a 6.7% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
